Neurocrine Biosciences Inc.
NBIX | NASDAQ
$145.85
-$0.25 (-0.17%)
Nov 2, 2026, 2:57 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 144.4M | 197.9M | 153.7M | 209.5M | 107.5M | 7.9M | 103.1M | 129.8M | 65M | 43.4M | 147.7M | 83.1M | 95.5M | -76.6M | 89M | 68.5M | -16.9M | 13.9M | -7.3M | 22.5M | 42.3M | 32.1M |
Depreciation & Amortization | 24.8M | 7.3M | 7.5M | 7.7M | 7.3M | 7.6M | 7.1M | 6.5M | 7.3M | 6.2M | 5.7M | 5.5M | 5.1M | 5M | 4.4M | 4M | 3.9M | 3.3M | 3M | 2.8M | 2.6M | 2.5M |
Stock-Based Compensation | 65M | 57.2M | 58.6M | 53.7M | 52.8M | 52.8M | 66.4M | 41.5M | 43.1M | 44.5M | 38.1M | 47.8M | 68.5M | 39.9M | 43.5M | 43.1M | 49.5M | 37M | 35.6M | 37.1M | 28.6M | 32.9M |
Other Working Capital | 10.7M | 74.1M | 84.2M | -40.6M | 38.5M | 14.9M | 103.9M | 20.6M | -63.4M | -21.4M | -31.4M | 73.5M | 87.6M | -17.6M | 41.1M | 14.3M | 41.2M | 800K | 31.6M | -18.5M | 21.8M | 12.7M |
Other Non-Cash Items | 7.6M | -52.5M | 1.2M | -26.5M | 10.9M | 33.9M | 2.9M | 10.7M | 76.8M | 83.4M | -34.9M | 33.8M | -41.4M | -4.4M | -5.9M | -10.2M | 79.3M | -18.7M | -27.3M | 14.7M | 7.3M | 6.1M |
Deferred Income Tax | -25.3M | -61.1M | 48.2M | 168.3M | -37.4M | -13.7M | -31.3M | -34.9M | -41.3M | -15.6M | 20.6M | -4.2M | -41.5M | -31.6M | 13.5M | 9M | -3.1M | -300K | -4.7M | 5.7M | 9.5M | -6.2M |
Change in Working Capital | -80.1M | -3M | 119.2M | -185.2M | -39.1M | -23.7M | 94.3M | 4.4M | -86.3M | -31.6M | -53.7M | 46M | 93.4M | -57.5M | -1.5M | -15.6M | 25.4M | -75.7M | 4.9M | -21M | 12.9M | 19.9M |
Operating Cash Flow | 136.4M | 145.8M | 388.4M | 227.5M | 102M | 64.8M | 242.5M | 158M | 64.6M | 130.3M | 123.5M | 212M | 179.6M | -125.2M | 143M | 98.8M | 138.1M | -40.5M | 4.2M | 61.8M | 103.2M | 87.3M |
Capital Expenditures | -7.8M | -9.1M | 2.4M | -13.2M | -12.5M | -10.7M | -7.3M | -8.1M | -11.6M | -11.2M | -5.4M | -7.6M | -6.8M | -8.5M | -1.8M | 1.7M | -8.8M | -7.6M | -8.9M | -5.7M | -4.3M | -4.5M |
Cash Acquisitions | -2.36B | 63.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -37.4M | -819.5M | -323M | -408.5M | -315.1M | -273.2M | -311.8M | -232.5M | -191.7M | -320.1M | -487.2M | -362.7M | -323.8M | -237.5M | -233.3M | -134.2M | -60.9M | -200.5M | -141.4M | -280.2M | -289.4M | -93.7M |
Sales Maturities Of Investments | 2.27B | 259.2M | 267.7M | 225M | 298.6M | 298.1M | 250.8M | 265.3M | 175.1M | 276.3M | 290.8M | 273M | 204.7M | 203.9M | 162.2M | 71.2M | 101.1M | 176.5M | 174M | 159.7M | 202.9M | 161.3M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -42.7M | 1.7M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -135.4M | -506.2M | -52.9M | -196.7M | -29M | 14.2M | -68.3M | 24.7M | -28.2M | -55M | -201.8M | -97.3M | -125.9M | -42.1M | -115.6M | -61.3M | 31.4M | -31.6M | 23.7M | -126.2M | -90.8M | 63.1M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -279M | n/a | n/a | n/a | n/a | -100K |
Common Stock Repurchased | -12M | -54M | n/a | n/a | -17.7M | -150M | -300M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -9.4M | -55.7M | n/a | n/a | n/a | n/a | n/a | n/a | -308.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 63.4M | -86.1M | 37.3M | 45.6M | -3.3M | -117.9M | -290M | 26.4M | -293M | 69.9M | 35.4M | 18.8M | 2.9M | 8.2M | 24.6M | 11.4M | -276.4M | 6.1M | 1.8M | 7.5M | 3M | 15.1M |
Net Cash Flow | 64.4M | -446.5M | 372.8M | 76.2M | 69.9M | -38.9M | -116.1M | 209.4M | -256.6M | 145.2M | -42.6M | 133.5M | 56.6M | -159.1M | 50.7M | 48.9M | -106.9M | -66M | 29.7M | -56.9M | 15.4M | 165.5M |
Free Cash Flow | 128.6M | 136.7M | 390.8M | 214.3M | 89.5M | 54.1M | 235.2M | 149.9M | 53M | 119.1M | 118.1M | 204.4M | 172.8M | -133.7M | 141.2M | 100.5M | 129.3M | -48.1M | -4.7M | 56.1M | 98.9M | 82.8M |
Adj. Free Cash Flow | 63.6M | 79.5M | 332.2M | 160.6M | 36.7M | 1.3M | 168.8M | 108.4M | 9.9M | 74.6M | 80M | 156.6M | 104.3M | -173.6M | 97.7M | 57.4M | 79.8M | -85.1M | -40.3M | 19M | 70.3M | 49.9M |
Maintenance CapEx | -7.8M | -7.3M | 4.8M | n/a | n/a | -639.27K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.4M | n/a | n/a | -854.17K | -993K | -4.3M | -4.5M |
Growth CapEx | n/a | -1.8M | -2.4M | -13.2M | -12.5M | -10.06M | -7.3M | -8.1M | -11.6M | -11.2M | -5.4M | -7.6M | -6.8M | -8.5M | -1.8M | -1.7M | -8.8M | -7.6M | -8.05M | -4.71M | n/a | n/a |
Owner Earnings | 128.6M | 138.5M | 393.2M | 227.5M | 102M | 64.16M | 242.5M | 158M | 64.6M | 130.3M | 123.5M | 212M | 179.6M | -125.2M | 143M | 102.2M | 138.1M | -40.5M | 3.35M | 60.81M | 98.9M | 82.8M |
Add to Watchlist
Select watchlists to add or remove NBIX